Jemincare Group Co., Ltd. was founded in 1999. Its pharmaceutical history can be traced back to the 1950s with 12,000 employees. Its headquarters is located in Nanchang, China. It has many industrial platforms and R&D institutes in Jiangxi, Beijing, Shanghai, Jiangsu and Zhejiang. In 2017, the group’s revenue exceeded 23.7 billion yuan, ranked the sixth in the top 100 of Chinese pharmacy industry and the tenth in the top 100 of Chinese medical industry. In according to innovation-driven strategies, Jemincare focus on R＆D, production and market of modern Chinese medicine, biological agents, health care products. It also has seven pharmaceutical bases, an international postdoctoral workstation, a CNAS certified national laboratory, five provincial engineering and technical centers and set up a new drug research and development team abroad. The core products are "Jinshuibao", "Xingnaojing", "Kanglaite", "Sineng", "Lixin", "Huang's Xiangsheng Pills", "Jiuhua Hemorrhoids Suppository", which has got high market shares of national subdivision category. Jemincare always adhering to the corporate mission of "Relieving the people, honest to the world " and devoting himself to the public welfare. Its various charitable donations totaled 317 million yuan. Looking forward to the future, Jemincare will continues to provide reliable medical products and services to improve the health level and life quality of human.